Evidence map›Paper›PMID 32964180›Full record

ArticleRheumatology advances in practice2020

The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study.

James Galloway, Jean-Philippe Capron, Francesco De Leonardis, Walid Fakhouri, Alison Rose, Ilias Kouris, Tom Burke

Open access · goldAbstract read
In one paragraph

Article in Rheumatology advances in practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Frontiers in immunology · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Work Ability and Quality of Life in Patients with Rheumatoid Arthritis.International journal of environmental research and public health · 2022
    Article
  16. Observational
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

James GallowayKing's College Hospital NHS Foundation Trust, Rheumatology, London, UK.
Jean-Philippe CapronPricing, Reimbursement and Access, Eli Lilly Benelux, Brussels, Belgium.
Francesco De LeonardisEli Lilly (Suisse) SA, Vernier, Switzerland.
Walid FakhouriEli Lilly Research & Development, Eli Lilly and Company, Windlesham, UK.
Alison RoseThe Innovation Centre, HCD Economics, Daresbury, UK.
Ilias KourisDepartment of Medicine-Rheumatology, Eli Lilly and Company, Indianapolis, IN, USA.
Tom BurkeThe Innovation Centre, HCD Economics, Daresbury, UK.
Element Six (United Kingdom) · GBEli Lilly (Switzerland) · CHEli Lilly (United Kingdom) · GBEli Lilly (United States) · USKing's College Hospital NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRA is a progressive, chronic autoimmune disease. We summarize the impact of disease activity as measured by the DAS in 28 joints (DAS28-CRP scores) and pain on productivity and ability to work using the Work Productivity and Activity Impairment questionnaire (WPAI) scores, in addition to the impact of disease duration on the ability to work.

methodsData were drawn from the Burden of RA across Europe: a Socioeconomic Survey (BRASS), a European cross-sectional study in RA. Analyses explored associations between DAS28-CRP score and disease duration with stopping work because of RA, and regression analyses assessed impacts of pain and DAS28-CRP on early retirement and WPAI.

resultsFour hundred and seventy-six RA specialist clinicians provided information on 4079 adults with RA, of whom 2087 completed the patient survey. Severe disease activity was associated with higher rates of stopping work or early retirement attributable to RA (21%)

conclusionResults demonstrate the high burden of RA. Furthermore, subjective domains, such as pain, could be as important as objective measures of RA activity in affecting the ability to work.

Indexed as

health economicsmanagementoutcome measurespain assessmentquality of liferheumatoid arthritis

Identifiers

PMID32964180
PMCPMC7494042
OpenAlexW3088321324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.